Kisspeptin-10
Also known as: Kp-10, Metastin 45-54, KISS1 peptide
Emerging neuroendocrine peptide — regulates reproductive hormones with promising fertility and libido applications.
Sexual Health
Kisspeptin-10
Research use only. Not FDA-approved. Clinical trials are ongoing. Use under endocrinology supervision.
Overview
Kisspeptin is a neuropeptide produced in the hypothalamus that serves as the primary regulator of the reproductive axis (HPG axis). Kisspeptin-10 is the shortest active fragment. It stimulates gonadotropin-releasing hormone (GnRH) release, leading to downstream increases in LH, FSH, testosterone, and estrogen. Used in clinical research for fertility treatment, hypogonadism, and sexual function.
Kisspeptin is a family of neuropeptides encoded by the KISS1 gene, with Kisspeptin-10 being the shortest biologically active fragment (10 amino acids). These peptides were originally identified as suppressors of cancer metastasis — reflected in the gene name KISS1, referencing the city of Hershey, Pennsylvania (home to the research group), with the chocolate kiss as a nod to the "Hershey Kiss" candy. The reproductive significance of Kisspeptin was discovered later when mutations in the Kisspeptin receptor (GPR54) were found to cause hypogonadotropic hypogonadism — complete failure of puberty and reproductive function — revealing its essential role in activating the reproductive axis.
Kisspeptin neurons in the hypothalamus function as the primary activators of GnRH (gonadotropin-releasing hormone) secretion — the master hormone that initiates the entire reproductive and testosterone production cascade. The signaling sequence is: Kisspeptin → activates hypothalamic GnRH neurons → GnRH pulses stimulate pituitary → pituitary releases LH and FSH → LH signals testes to produce testosterone → testosterone feeds back to regulate the system. Kisspeptin represents the highest level of endogenous control over this axis that can currently be targeted pharmacologically, sitting upstream of every other intervention in conventional hormonal medicine including Clomid (which targets estrogen receptors at the pituitary) and hCG (which mimics LH directly at the testes).
This upstream position makes Kisspeptin particularly interesting for cases where the reproductive axis has been suppressed at the hypothalamic level — which is precisely what occurs with exogenous androgen use. Steroids and testosterone therapy suppress the reproductive axis through negative feedback, but this suppression acts primarily on GnRH neurons (via sex steroid receptors on those same neurons). Restoring GnRH pulsatility after prolonged suppression is the core challenge of post-cycle recovery, and conventional PCT agents (Clomid, Nolvadex, hCG) address this from further downstream in the cascade. Kisspeptin-10 addresses it at the source.
Published research has demonstrated that exogenous Kisspeptin-10 administration robustly stimulates LH, FSH, and testosterone secretion in men with both normal and suppressed reproductive axes. Clinical studies in hypogonadotropic hypogonadism patients (where GnRH neurons are dysfunctional) show that pulsatile Kisspeptin-10 infusion can partially restore reproductive hormones and even fertility. Research into its practical utility for anabolic steroid-related hypothalamic suppression is ongoing, with growing interest from sports medicine and hormone optimization communities.
Mechanism of Action
Kisspeptin binds KISS1 receptors on GnRH neurons in the hypothalamus, causing robust pulsatile GnRH release. This stimulates LH and FSH from the pituitary, which drives gonadal hormone production. The pathway is essential for puberty onset and maintenance of reproductive function.
Use Cases
- ✓Hypogonadotropic hypogonadism
- ✓Male fertility and testosterone optimization
- ✓Female fertility treatment
- ✓Libido enhancement
- ✓Post-TRT/steroid recovery (HPTA restoration)
Research Summary
Clinical trials at multiple academic medical centers have demonstrated kisspeptin's ability to stimulate LH and testosterone in hypogonadal males and trigger ovulation in females with hypothalamic amenorrhea. Published Phase I/II studies show excellent safety and tolerability.
Explain It Like I'm 5 Years Old
Way deep in your brain, there's a master switch for your entire reproductive system — everything that makes you produce sex hormones flows from this one switch. Kisspeptin-10 is what flips that master switch. When it turns on, it starts a whole chain reaction: the chain goes to another gland, which then goes to your testes or ovaries to produce testosterone or estrogen.
How the Gym Bros Are Using It
The upstream HPTA reset peptide gaining serious attention in the post-cycle community. Kisspeptin works further up the hormonal chain than anything in a standard PCT — it activates the very neurons that drive GnRH release, which then drives LH, which then drives testosterone production. For guys coming off a long steroid run or extended TRT, this is the peptide that restarts the engine at the source. Not fully mainstream yet but the research is legitimate and the PCT community is very interested. Also relevant for secondary hypogonadism cases that are borderline for TRT.
Typical Dosing
Research protocols vary: 0.25–3 nmol/kg IV in studies. Subcutaneous doses in practice range 2–10 mcg/kg.
Administration
Research Chemical
Research use only. Not FDA-approved. Clinical trials are ongoing. Use under endocrinology supervision.
